Srikosha Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-01-2025
- Paid Up Capital ₹ 0.10 M
as on 09-01-2025
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 46.60%
(FY 2020)
- Ebitda 46.60%
(FY 2020)
- Net Worth -44.76%
(FY 2020)
- Total Assets -9.58%
(FY 2020)
About Srikosha Lifesciences
The Corporate was formerly known as Srikosha Ayurveda Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Adilakshmi Muppa and Srinivasulu Muppa serve as directors at the Company.
- CIN/LLPIN
U24100TG2018PTC124441
- Company No.
124441
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Srikosha Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Adilakshmi Muppa  | Director | 14-May-2018 | Current |
| Srinivasulu Muppa | Director | 14-May-2018 | Current |
Financial Performance of Srikosha Lifesciences.
Srikosha Lifesciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 46.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Srikosha Lifesciences?
In 2020, Srikosha Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aadi Motors Private LimitedActive 21 years 2 monthsAdilakshmi Muppa and Srinivasulu Muppa are mutual person
- Shivam Amusements Private LimitedActive 11 years 6 months
Adilakshmi Muppa and Srinivasulu Muppa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Srikosha Lifesciences?
Unlock and access historical data on people associated with Srikosha Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Srikosha Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srikosha Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
